GLI-8545

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGLI-8545
Drug Alias NameGLI-8545
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-reactive protein inhibitors
TargetsC-reactive protein
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalileo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalileo Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A